Novel retroviral packaging cell lines: complementary tropisms and improved vector production for efficient gene transfer (original) (raw)

• Paper
• Published: 01 June 1997

Gene Therapy volume 4, pages 600–610 (1997)Cite this article

• 799 Accesses
• 35 Citations
• 3 Altmetric
• Metrics details

Abstract

We report increased transduction of human hematopoietic progenitor cells through a combination of novel retroviral vector packaging cell lines, and improved vector supernatant production. The new ProPak packaging cell lines produce either murine leukemia virus (MLV) xenotropic (ProPak-X cells) or amphotropic particles (ProPak-A cells), and ProPak-based producer cells were demonstrated to be free of replication-competent retrovirus (RCR) by stringent testing. Vector supernatants from ProPak or existing packaging cell lines producing different pseudotyped particles (amphotropic MLV, xenotropic MLV or gibbon ape leukemia virus) were compared for the ability to transduce clinically relevant human hematopoietic cells. All vector types transduced primary human CD34-positive or CD4-positive cells, regardless of tropism. However, consistently higher transduction of target cells was achieved with ProPak-derived amphotropic vector than with PA317-packaged amphotropic vector. The highest transduction of human hematopoietic progenitor cells was achieved with vector supernatant generated from a coculture of the ProPak-X and ProPak-A cell lines. This ping-pong amplification yielded supernatant containing vector targeted to two distinct receptors present on human cells, and did not result in detectable RCR formation. In addition, we describe conditions for improved vector supernatant production in a packed-bed bioreactor.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

• Purchase on SpringerLink
• Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

• Log in
• Learn about institutional subscriptions
• Read our FAQs
• Contact customer support

Similar content being viewed by others

Author information

Authors and Affiliations

1. Progenesys Program, SyStemix Inc., 3155 Porter Drive, Palo Alto, 94304, CA, USA
   SP Forestell, JS Dando, J Chen, P de Vries, E Böhnlein & RJ Rigg
2. Gene Therapy Programme, DIBIT HS Raffaele, Milan, Italy
   JS Dando
3. Cell Therapeutics, Seattle, Washington, USA
   P de Vries

Authors

1. SP Forestell
   You can also search for this author inPubMed Google Scholar
2. JS Dando
   You can also search for this author inPubMed Google Scholar
3. J Chen
   You can also search for this author inPubMed Google Scholar
4. P de Vries
   You can also search for this author inPubMed Google Scholar
5. E Böhnlein
   You can also search for this author inPubMed Google Scholar
6. RJ Rigg
   You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Forestell, S., Dando, J., Chen, J. et al. Novel retroviral packaging cell lines: complementary tropisms and improved vector production for efficient gene transfer.Gene Ther 4, 600–610 (1997). https://doi.org/10.1038/sj.gt.3300420

Download citation

• Received: 22 October 1996
• Accepted: 27 January 1997
• Issue Date: 01 June 1997
• DOI: https://doi.org/10.1038/sj.gt.3300420

Keywords

This article is cited by